BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5260586)

  • 1. [Combination treatment of acute leukemia in the child with dauno-rubidomycin].
    Sachtleben P; Binder H; Krämer D; Weyrich C; Chwartz W
    Dtsch Med Wochenschr; 1969 Sep; 94(39):1972-4 passim. PubMed ID: 5260586
    [No Abstract]   [Full Text] [Related]  

  • 2. Vincristine, prednisone, and daunomycin in acute leukemia of childhood.
    Vietti TJ; Starling K; Wilbur JR; Lonsdale D; Lane DM
    Cancer; 1971 Mar; 27(3):602-7. PubMed ID: 5279331
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute lymphoblastic leukemia in childhood. Epicritical evaluation of 2 therapeutic regimes].
    Madon E; Cordero di Montezemolo L; Pastore G; Grazia G
    Minerva Pediatr; 1979 Jun; 31(12):909-14. PubMed ID: 288971
    [No Abstract]   [Full Text] [Related]  

  • 6. Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group.
    van der Does-van den Berg A; van Wering ER; de Koning J; Rammeloo JA; Solbu G; Suciu S; van Zanen GE
    Haematol Blood Transfus; 1987; 30():444-7. PubMed ID: 3305211
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of acute leukemia.
    Holland JF
    Hamatol Bluttransfus; 1970; 9():58-65. PubMed ID: 5279393
    [No Abstract]   [Full Text] [Related]  

  • 8. Daunorubicin. Results in childhood leukaemia.
    Matthews RN; Colebatch JH
    Arch Dis Child; 1972 Apr; 47(252):272-7. PubMed ID: 4502569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia.
    Holton CP; Vietti TJ; Nora AH; Donaldson MH; Stuckey WJ; Watkins WL; Lane DM
    N Engl J Med; 1969 Jan; 280(4):171-4. PubMed ID: 5248383
    [No Abstract]   [Full Text] [Related]  

  • 10. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
    Paciucci PA; Keaveney C; Cuttner J; Holland JF
    Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse.
    Pavlovsky S; Muriel FS; Eppinger-Helft M; Bustelo P; Garay G; Giuntoli JM; Kvicala R; Divito J; Picón A
    Cancer Treat Rep; 1983 May; 67(5):425-7. PubMed ID: 6573958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
    Aur RJ; Simone JV; Pratt CB
    Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG; Reaman GH; Wesley R
    Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the method of reinduction during the treatment of acute lymphoblastic leukemia].
    Jacquillat C; Weil M; Boiron M
    Therapeutique; 1971 Apr; 47(4):403-5. PubMed ID: 5284341
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the treatment of lymphoblastic leukemia in children].
    Radwańska U
    Acta Haematol Pol; 1984; 15(3-4):203-11. PubMed ID: 6399432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of acute lymphoblastic leukemia treatment in children. (Apropos of 58 cases)].
    Goudemand M; Bauters F; Lerche B
    Lille Med; 1972 Feb; 17(2):220-7. PubMed ID: 4504533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leukocytic changes under treatment with L-asparaginase].
    Kolarz G; Pietschmann H
    Wien Med Wochenschr; 1971 Mar; 121(11):196-9. PubMed ID: 4254383
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-Asparaginase in the treatment of acute leukemia].
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
    Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.